Balancing Opioid Policy and Pain Management

Is Washington finally ready to address the nation’s opioid crisis in a meaningful way? Thursday marked the White House Opioid Summit, which welcomed 200 affected

Read More

Making Treatment Less Rare for Rare Disease Patients

Waiting is a fact of life for patients with rare diseases such as cystic fibrosis.   Many of these men and women, whose disease causes

Read More

Should Medicaid Patients be Required to Work?

Patients covered by Medicaid in Kentucky and Indiana could soon find themselves in a difficult position. According to new rules, recipients must complete 80 hours

Read More

New Video Explains Drug Track-and-Trace Process

It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on

Read More

Veterans Issues Dominate Headache Policy Event

Add migraine to the long list of battles faced by veterans of the United States Armed Services. In a Tuesday policy panel sponsored by The

Read More

Cystic Fibrosis Community Celebrates New Treatment Option

The cystic fibrosis community received news worth celebrating this week. The Food and Drug Administration approved a new drug that helps address the underlying cause

Read More

Aetna Debacle Deepens Skepticism about Coverage Decisions

Think an informed medical expert is making the coverage decisions at your health insurance company?  You might think again. In a story that’s sending ripples

Read More

New Gout Alliance Releases “Fast Facts”

Gout can be painful and debilitating – but also treatable, explains a new Fast Facts policy brief. A product of the newly formed Alliance for

Read More

Epilepsy Day Highlights Access Challenges for Patients

More than 3.4 million people in the United States live with epilepsy, a neurological disorder that can cause seizures and violent muscle spasms. This February

Read More

Is the Right to Try Act Right for Patients?

“Patients with terminal conditions should have access to experimental treatments that could potentially save their lives,” declared President Donald Trump in his first State of

Read More
Back to Top